Serum levels of L-arginine analogues and glutathione peroxidase and catalase gene variants in Type 2 diabetes mellitus patients [4]

Diabetic Medicine

Volumn 22, Issue 3, 2005, Pages 356-357

  Szelestei, T ^a   Bahring S ^b   Wagner, Z ^a   Aydint, A ^b   Molnar G A ^a   Kocsis, B ^a   Nagy, J ^a   Wittmann, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; ARGININE DERIVATIVE; CATALASE; GLUTATHIONE PEROXIDASE; METFORMIN; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PROBUCOL;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIOXIDANT ACTIVITY; BIOSYNTHESIS; BLOOD LEVEL; BLOOD VESSEL TONE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; GPX 1 GENE; HUMAN; INSULIN RESISTANCE; LETTER; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; VASODILATATION;

AGED; ARGININE; CATALASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HUNGARY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 14644405607     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01423.x     Document Type: Letter

References (9)

1. Chan NN, Chan JC. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 2002; 45: 1609-1616.
2. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287: 1420-1426.
3. Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP et al. Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism 2002; 51: 843-846.
4. Jiang JL, Li Ns NS, Li YJ, Deng HW. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br J Pharmacol 2002; 135: 1175-1182.
5. Forsberg L, de Faire U, Morgenstern R. Low yield of polymorphisms from EST blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Hum Mutat 1999; 13: 294-300.
6. Forsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-505.
7. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001; 358: 2127-2128.
8. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349: 1605-1613.
9. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623-634.